1. Home
  2. Drug Recall Enforcement Reports
  3. Recall Enforcement Event ID: 98181

Recall Enforment Report D-0251-2026

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Imprimis NJOF, LLC, originally initiated on 12-18-2025 for the product Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06. The product was recalled due to presence of particulate matter - glass like particles.. The product was distributed nationwide and the recall is currently ongoing.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-0251-202612-18-202501-14-2026Class II314 boxes of 6,280 pre-filled syringesTri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.Presence of particulate matter - Glass like particles.Ongoing
D-0250-202612-18-202501-14-2026Class II596 boxes of 11,920 pre-filled syringesDexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.Presence of particulate matter - Glass like particles.Ongoing
D-0249-202612-18-202501-14-2026Class II778 boxes of 15,540 pre-filled syringesDexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1Presence of particulate matter - Glass like particles.Ongoing